Skip to main content
logo
MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,286.00
+90.00 (7.53%)
Sep 1, 2026, 3:30 PM KST

MYUNGMOON Pharm co.,Ltd Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
199,825195,247186,443169,567152,135137,760
Revenue Growth
4.75%4.72%9.95%11.46%10.44%7.75%
Gross Profit
110,992106,386104,49494,90977,60761,795
Operating Income
1,5236,8351,929963.776,434-5,881
Net Income
-1,6691,895-3,035-4,5257,868-6,865
Earnings Per Share
-49.5756.70-91.00-134.35232.74-203.06
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
24,3056,1454,75811,6649,98410,517
Total Debt
87,14898,63487,50590,48283,15784,130
Net Cash (Debt)
-62,842-92,489-82,748-78,818-73,173-73,614
Net Cash Growth
------
Net Cash Per Share
-1867.13-2766.78-2481.48-2340.26-2164.50-2177.55

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3,551-1,704-1,338-5,1815,475855
Capital Expenditures
-6,358-6,758-771.52-2,983-1,731-374.71
Free Cash Flow
-9,909-8,462-2,109-8,1643,744480.28
Free Cash Flow Growth
----679.57%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
55.55%54.49%56.05%55.97%51.01%44.86%
Operating Margin
0.76%3.50%1.03%0.57%4.23%-4.27%
Pretax Margin
-1.18%1.36%-2.01%-2.82%1.74%-4.79%
Profit Margin
-0.83%0.97%-1.63%-2.67%5.17%-4.98%
FCF Margin
-4.96%-4.33%-1.13%-4.81%2.46%0.35%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-32.63--12.33-
P/FCF Ratio
----25.91332.93
PS Ratio
0.220.320.330.450.641.16